NantHealth (NantHealth) Earnings per Share (Diluted) : $-8.19 (TTM As of Sep. 2023)

View and export this data going back to 2016. Start your Free Trial

What is NantHealth Earnings per Share (Diluted)?

NantHealth's Earnings per Share (Diluted) for the three months ended in Sep. 2023 was $-1.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-8.19.

NantHealth's EPS (Basic) for the three months ended in Sep. 2023 was $-1.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2023 was $-8.19.

NantHealth's EPS without NRI for the three months ended in Sep. 2023 was $-0.53. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2023 was $-6.87.

During the past 3 years, the average EPS without NRIGrowth Rate was -1.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was 17.10% per year.

During the past 9 years, NantHealth's highest 3-Year average EPS without NRI Growth Rate was 33.50% per year. The lowest was -66.30% per year. And the median was 4.45% per year.

NantHealth Earnings per Share (Diluted) Historical Data

The historical data trend for NantHealth's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NantHealth Earnings per Share (Diluted) Chart

NantHealth Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Earnings per Share (Diluted)

Get a 7-Day Free Trial

-26.40

-8.55

-7.65

-7.66

-8.80

NantHealth Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Earnings per Share (Diluted)	Get a 7-Day Free Trial															-1.77	-3.33	-1.59	-2.27	-1.00

Competitive Comparison of NantHealth's Earnings per Share (Diluted)

For the Health Information Services subindustry, NantHealth's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NantHealth's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NantHealth's PE Ratio distribution charts can be found below:

* The bar in red indicates where NantHealth's PE Ratio falls into.

NantHealth Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

NantHealth's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2022 is calculated as

Diluted Earnings Per Share (A: Dec. 2022 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-67.779	-	0)	/	7.703
	=	-8.80

NantHealth's Earnings Per Share (Diluted) for the quarter that ended in Sep. 2023 is calculated as

Diluted Earnings Per Share (Q: Sep. 2023 )	=	(Net Income	-	Preferred Dividends	/	Shares Outstanding (Diluted Average)
	=	(-14.987	-	0)	/	15.009
	=	-1.00

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.19

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.

NantHealth (OTCPK:NHIQ) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

NantHealth Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of NantHealth's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

NantHealth (NantHealth) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NantHealth Inc (OTCPK:NHIQ) » Definitions » Earnings per Share (Diluted)

Comparable Companies

Traded in Other Exchanges

N/A

Address

3000 RDU Center Drive, Suite 200, Morrisville, NC, USA, 27500

Website

https://www.nanthealth.com

NantHealth Inc is a healthcare company that employs precision medicine and technology to give physicians, payers, and patients more information. The company develops software and hardware to collect, indexes, analyze and interpret molecular, financial, clinical, and operational data points to improve decision-making. The company provides cancer care solutions, provide solutions, and payer solutions.

Executives

Rao Haris Naseem	director, 10 percent owner, officer: Chief Executive Officer	C/O NANTHEALTH, INC., 760 W. FIRE TOWER RD., SUITE 107, WINTERVILLE NC 28590
Summus Holdings Llc	10 percent owner	2871 LAKE VISTA DR, SUITE 210, LEWISVILLE TX 75067
Ronald Allen Louks	officer: Chief Operating Officer	C/O NANTHEALTH, INC., 9920 JEFFERSON BLVD., CULVER CITY CA 90232
Nant Capital, Llc	10 percent owner	9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Patrick Soon-shiong	director, 10 percent owner, officer: See Remarks	9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Deanna L. Wise	director	C/O NANTHEALTH, INC., 9920 JEFFERSON BLVD, CULVER CITY CA 90232
Bob Petrou	officer: Interim CFO	C/O NANTHEALTH, INC., 9920 JEFFERSON BLVD., CULVER CITY CA 90232
Mp 13 Ventures, Llc	10 percent owner	9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Cambridge Equities, Lp	10 percent owner	9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Allscripts Healthcare Solutions, Inc.	10 percent owner	222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Nantworks, Llc	10 percent owner	9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Investment Office Kuwait	10 percent owner	15 CARTER LANE, LONDON X0 EC4V 5EY
Miller Edward D Jr	director	JOHNS HOPKINS, 733 NORTH BROADWAY - SUITE 100, BALTIMORE MD 21205
Kuwait Investment Authority On Behalf Of The Govt Of Kuwait	10 percent owner	C/O HOMEPLACE OF AMERICA INC, 3200 POTTERY DRIVE, MYRTLE BEACH SC 29579
James Mark Burnett	director	640 N. SEPULVEDA BLVD., LOS ANGELES CA 90049